Septerna Inc (SEPN) - Earnings growth in current year
The history of annual net income per share growth demonstrates a development trend where -29.90 records a new level. Septerna Inc (SEPN) utilizes a proprietary small molecule discovery system that creates a technological foundation to be validated during testing. The absence of current revenue and reliance on external capital create financial risks. Meanwhile, the focus on endocrine pathologies expands the potential patient market.
Financial and market metric breakdowns for Septerna Inc (SEPN)
- price and consensus price forecast:
- market capitalization indicators:
- book capitalization data:
- debt and liquidity details:
Total Debt to Capital Coefficient Septerna Inc|SEPN - Long-Term Debt to Capital|Current Liabilities to Capital septerna.com|SEPN - Company Debts|Debts to Book Capitalization Ratio Septerna Pharma|SEPN - Company Long-Term Liabilities|Amount of Current Liabilities Septerna|Immediate Liquidity septerna.com
- earnings and market ratios statistics:
SEPN - Company Net Income|Expected Net Income Septerna Inc|SEPN - Price to Earnings Ratio|Price to Future Earnings Ratio Septerna Pharma|SEPN - PEG Multiple|EV/EBITDA Multiple Septerna Pharma|SEPN - Operating profit before deduction of amortization|Earnings per share for the trailing year Septerna|SEPN - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months septerna.com|SEPN - Earnings per share growth in current year|Projected earnings per share growth rate for next year Septerna Inc
Basic company analysis:Septerna, Inc. SEPN
Septerna Inc (SEPN) development of innovative GPCR receptor therapies for treating metabolic pathologies requires colossal investments, which directly impacts the bottom-line net income. By analyzing the relative EPS YoY dynamics, an investor assesses the annual percentage change in earnings per share to determine the business's ability to generate income against operating expenses and its resilience to external market shocks.
Key competitors
Net earnings per share growth this year argenx N.V.|Net earnings per share growth this year BNTX|Earnings growth in current year abivax.com|Earnings per share growth in current year ADMA Biologics (ADMA)|protagonist-inc.com - Earnings per share growth this year|Earnings growth in current year IMVT (Immunovant)|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Earnings per share growth rate in current year|GRFS - Earnings per share growth in current year|Expected net earnings per share growth this year Adaptive Biotechnologies Inc. ADPT|CLDX: Earnings growth in current year|Earnings per share growth rate in current year auriniapharma.com (AUPH)|Earnings per share growth in current year BioCryst Pharmaceuticals|Vera Therapeutics Inc - Earnings per share trend in current year|Net earnings per share growth this year DNTH (Dianthus Pharma)|Net earnings per one share growth for the current year PHVS|Earnings growth in current year ABCL (AbCellera Biologics)|tourmalinebio.com (TRML) - Earnings per share growth rate in current year|PGEN - Earnings per share growth in current year|Earnings per share increase in current year PHAR (Pharming Group NV)|Nektar (NKTR) - Earnings per share growth in current year|Earnings per share growth this year UPB|ZBIO (Zenas Biopharma Inc) - Earnings growth in current year|Earnings growth in current year immunome.com|Net earnings per share growth this year GOSS (Gossamer Bio)|KALV (KalVista Pharma) - Earnings per share increase in current year|Earnings growth in current year PVLA (Pieris Pharmaceuticals Inc)|Expected net earnings per share growth this year Savara Pharma (SVRA)|RIGL - Earnings per share growth in current year|ANAB (anaptysbio.com) - Earnings per share growth this year|ATXS: Earnings growth in current year|Net earnings per share growth this year enGene Holdings Inc|Earnings per share growth in current year RAPT Therapeutics|Aerovate (JBIO) - Expected net earnings per share growth this year|Earnings growth in current year ACRS|KYTX - Earnings per share growth rate in current year|Earnings per share growth in current year Tiziana Life Sciences Ltd TLSA|CABA (Cabaletta Bio Inc.) - Earnings per share trend in current year|VTYX - Earnings per share growth in current year|THTX (Theratechnologies, Inc) - Earnings per share growth this year|Avalo Therapeutics, Inc (AVTX) - Earnings per share growth in current year|Earnings per share trend in current year ELDN (eledon.com)|AGEN (Agenus Inc.) - Earnings growth in current year|CLYM: Earnings per share increase in current year|Earnings growth in current year ZURA|Earnings growth in current year aTyr Pharmaceuticals (ATYR)|Earnings per share growth in current year Adagene Inc. ADAG|Earnings per share increase in current year IMA|STTK - Earnings per share growth in current year|Equillium, Inc. (EQ) - Net earnings per share growth this year|CNTB: Earnings growth in current year|Immunic (IMUX) - Earnings growth in current year|Net earnings per share growth this year ATRA|IFRX: Earnings per share increase in current year|Earnings growth in current year XFOR|Expected net earnings per share growth this year adicetbio.com|Earnings per share growth in current year Celularity CELU|INMB - Net earnings per share growth this year|BRNS - Earnings per share growth in current year|kezarlifesciences.com (KZR) - Net earnings per share growth this year|SABS (SAB Biotherapeutics, Inc.) - Net earnings per share growth this year|Akari Therapeutics PLC (AKTX) - Earnings growth in current year|Earnings per share growth in current year Enlivex Therapeutics Ltd|Earnings per share growth this year QTTB (Q32 Bio Corp)|Earnings growth in current year GOVX|EDSA - Earnings per share growth rate in current year|Earnings per share growth in current year iBio IBIO|Expected net earnings per share growth this year Carisma Therapeutics Inc (CARM)|XTL Biopharmaceuticals, Ltd. - Earnings growth in current year|Earnings per share growth rate in current year Bolt Biotherapeutics|hcwbiologics.com (HCWB) - Earnings per share growth in current year|Earnings per share trend in current year APVO (Aptevo Therapeutics Inc.)|Net earnings per share growth this year AIM|ADTX (Aditxt Corp) - Net earnings per one share growth for the current year|Earnings growth in current year GRI|XRTX - Earnings per share growth rate in current year|Earnings per share growth in current year Vyome Holdings Inc HIND|Earnings per share increase in current year REVB|INDP - Earnings per share growth in current year|SCNI (Scinai Immunotherapeutics Ltd) - Earnings per share growth this year|CALI: Earnings growth in current year|Affimed N.V. (AFMD) - Earnings growth in current year|Net earnings per share growth this year ALLK|HOOK: Earnings per share increase in current year|Earnings growth in current year IGMS|Expected net earnings per share growth this year iTeos Therapeutics Inc|Earnings per share growth in current year Ocean Bio OCEA|TCBP: Earnings per share growth this year|Third Harmonic Bio - Earnings growth in current year
